10-Q Filing

Talkspace, Inc. CIK: 1803901 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-001074`
Period End Date	20210630
Filing Date	20210809
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	talk-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 71 Cash Flow Statement 56 Stockholders Equity 36

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$248.17M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.02M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.62M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$5.91M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.32M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.51M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$259.11M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$549.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$175.00K	USD	Point-in-time
Deferred issuance cost	`DeferredCosts`	$692.00K	USD	Point-in-time
Deferred issuance cost	`DeferredCosts`	-	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.20M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.32M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$6.13M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	129.40M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$98.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.41M	shares	Point-in-time
Total assets	`Assets`	$32.87M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	152.26M	shares	Point-in-time
Total assets	`Assets`	$270.20M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Accounts payable	`AccountsPayableCurrent`	$7.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.76M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$5.17M	USD	Point-in-time
Deferred revenues	`ContractWithCustomerLiabilityCurrent`	$7.55M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$9.64M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilitiesCurrent`	$7.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.49M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.95M	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	-	USD	Point-in-time
Warrant liabilities	`WarrantLiabilitiesNonCurrent`	$38.90M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	-	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$98.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$67.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.49M	USD	Point-in-time
Convertible preferred stock (Series Seed, Seed-1, Seed-2, A, B, C and D) of 0.0001 par value -- Authorized: 100,000,000 and 95,709,146 shares at June 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 0 and 94,582,550 shares at June 30, 2021 and December 31, 2021, respectively (1)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$111.28M	USD	Point-in-time
Convertible preferred stock (Series Seed, Seed-1, Seed-2, A, B, C and D) of 0.0001 par value -- Authorized: 100,000,000 and 95,709,146 shares at June 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 0 and 94,582,550 shares at June 30, 2021 and December 31, 2021, respectively (1)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	-	USD	Point-in-time
Common stock of 0.0001 par value -- Authorized: 1,000,000,000 and 129,397,278 shares at June 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 152,255,736 and 13,413,431 shares at June 30, 2021 and December 31, 2020, respectively (1)	`CommonStockValue`	$15.00K	USD	Point-in-time
Common stock of 0.0001 par value -- Authorized: 1,000,000,000 and 129,397,278 shares at June 30, 2021 and December 31, 2020, respectively; Issued and outstanding: 152,255,736 and 13,413,431 shares at June 30, 2021 and December 31, 2020, respectively (1)	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital (1)	`AdditionalPaidInCapital`	$9.89M	USD	Point-in-time
Additional paid-in capital (1)	`AdditionalPaidInCapital`	$354.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-108.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-151.97M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$202.26M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-87.35M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-87.04M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$270.20M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$32.87M	USD	Point-in-time

Income Statement 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$17.88M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$30.98M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$58.14M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$29.00M	USD	2 Qtrs
Cost of Revenues	`CostOfRevenue`	$21.51M	USD	2 Qtrs
Cost of Revenues	`CostOfRevenue`	$11.70M	USD	1 Quarter
Cost of Revenues	`CostOfRevenue`	$5.57M	USD	1 Quarter
Cost of Revenues	`CostOfRevenue`	$10.98M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$19.29M	USD	1 Quarter
Gross Profit	`GrossProfit`	$12.31M	USD	1 Quarter
Gross Profit	`GrossProfit`	$18.02M	USD	2 Qtrs
Gross Profit	`GrossProfit`	$36.63M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$4.78M	USD	1 Quarter
Research and development, net	`ResearchAndDevelopmentExpense`	$5.13M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$7.75M	USD	2 Qtrs
Research and development, net	`ResearchAndDevelopmentExpense`	$2.40M	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$1.91M	USD	1 Quarter
Clinical operations	`OtherCostAndExpenseOperating`	$1.64M	USD	2 Qtrs
Clinical operations	`OtherCostAndExpenseOperating`	$3.99M	USD	2 Qtrs
Clinical operations	`OtherCostAndExpenseOperating`	$759.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$8.44M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$17.36M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$48.69M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$26.44M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.46M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$16.32M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.35M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$13.71M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$76.75M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$12.95M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$46.85M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$26.59M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-641.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-27.56M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-40.12M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-8.57M	USD	2 Qtrs
Financial expense (income), net	`InterestAndDebtExpenseIncome`	$2.87M	USD	1 Quarter
Financial expense (income), net	`InterestAndDebtExpenseIncome`	$-31.00K	USD	2 Qtrs
Financial expense (income), net	`InterestAndDebtExpenseIncome`	$-1.00K	USD	1 Quarter
Financial expense (income), net	`InterestAndDebtExpenseIncome`	$3.04M	USD	2 Qtrs
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.54M	USD	2 Qtrs
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-30.43M	USD	1 Quarter
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-43.16M	USD	2 Qtrs
Loss before taxes on income	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-640.00K	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$10.00K	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$6.00K	USD	1 Quarter
Taxes on income	`IncomeTaxExpenseBenefit`	$9.00K	USD	2 Qtrs
Taxes on income	`IncomeTaxExpenseBenefit`	$18.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-646.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.18M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.55M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.55M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-646.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-30.44M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.18M	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$1.15	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$2.15	USD	2 Qtrs
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$0.05	USD	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	$0.64	USD	2 Qtrs
Weighted average number of common shares used in computing basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.10M	shares	2 Qtrs
Weighted average number of common shares used in computing basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	26.36M	shares	1 Quarter
Weighted average number of common shares used in computing basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.37M	shares	1 Quarter
Weighted average number of common shares used in computing basic and diluted net loss per share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.33M	shares	2 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-646.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.18M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.55M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$955.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$36.00K	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$175.00K	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$16.71M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$733.00K	USD	2 Qtrs
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	$-3.04M	USD	2 Qtrs
Warrant issuance cost and change in fair value	`WarrantIssuanceCostAndChangeInFairValue`	-	USD	2 Qtrs
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$703.00K	USD	2 Qtrs
Increase in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$785.00K	USD	2 Qtrs
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$556.00K	USD	2 Qtrs
Increase in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.78M	USD	2 Qtrs
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-326.00K	USD	2 Qtrs
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.83M	USD	2 Qtrs
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$2.07M	USD	2 Qtrs
Increase in deferred revenues	`IncreaseDecreaseInDeferredCharges`	$2.38M	USD	2 Qtrs
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-213.00K	USD	2 Qtrs
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-286.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-17.79M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.66M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$449.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-449.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.00K	USD	2 Qtrs
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	-	USD	2 Qtrs
Proceeds from reverse capitalization, net of transaction costs	`ProceedsFromReverseCapitalizationNetOfTransactionCosts`	$251.32M	USD	2 Qtrs
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	-	USD	2 Qtrs
Proceeds from borrowings	`ProceedsFromIssuanceOfDebt`	$6.00M	USD	2 Qtrs
Repayment of borrowings	`RepaymentsOfDebt`	$6.00M	USD	2 Qtrs
Repayment of borrowings	`RepaymentsOfDebt`	-	USD	2 Qtrs
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$50.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$62.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.89M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$62.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$253.16M	USD	2 Qtrs
Change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$234.93M	USD	2 Qtrs
Change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-7.61M	USD	2 Qtrs
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$248.17M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$32.02M	USD	Point-in-time
Cash and cash equivalents at the beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$248.17M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$39.63M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$32.02M	USD	Point-in-time
Cash and cash equivalents at the end of the period	`CashAndCashEquivalentsAtCarryingValue`	$13.25M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$101.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$19.00K	USD	2 Qtrs
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Conversion of preferred stock to common stock	`ConversionOfStockAmountConverted1`	$111.28M	USD	2 Qtrs

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Common stock, conversion ratio	`StockholdersEquityNoteStockSplitConversionRatio1`	1.13	pure	2 Qtrs
Beginning balance, value	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$202.26M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-87.35M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-87.04M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time
Common stock issued related to exercise of warrants, value	`StockIssuedDuringPeriodValueWarrants`	$609.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodSharesStockOptionsExercised`	3.30M	shares	2 Qtrs
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00K	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.13M	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	1 Quarter
Exercise of stock options , Value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$797.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.20M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$332.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.51M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$401.00K	USD	1 Quarter
Preferred stock conversion, Value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$111.28M	USD	1 Quarter
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$125.00K	USD	1 Quarter
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$27.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-646.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.90M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.18M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-30.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.74M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.55M	USD	2 Qtrs
Ending balance, value	`StockholdersEquity`	$-109.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$202.26M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-87.35M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-87.04M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-98.90M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-79.60M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	13.41M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	152.26M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.